THANMAYIE BETHI

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CLARKSTON, GA NPI 1962038307

General Payments — all program years on this page

$267.37

  • Category: General Payments
  • Program years: PY2024
  • Record count: 15
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $267.37 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $267.3715

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
GlaxoSmithKline, LLC. $67.364
Acerta Pharma LLC $48.083
Novo Nordisk AS $40.992
ABBVIE INC. $31.982
PFIZER INC. $25.301
SHIELD THERAPEUTICS INC $23.371
Kowa Pharmaceuticals America, Inc. $15.871
Lilly USA, LLC $14.421

By program year

Program yearAmountRecords
2024 $267.3715

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100253738 Novo Nordisk Inc $23.20 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100620908 Novo Nordisk Inc $17.79 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104376953 AstraZeneca Pharmaceuticals LP $18.08 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104642857 AstraZeneca Pharmaceuticals LP $13.59 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105790708 AstraZeneca Pharmaceuticals LP $16.41 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106522150 ABBVIE INC. $13.53 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106522152 ABBVIE INC. $18.45 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113472231 Kowa Pharmaceuticals America, Inc. $15.87 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116370651 GlaxoSmithKline, LLC. $17.79 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116570085 GlaxoSmithKline, LLC. $15.42 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116638022 GlaxoSmithKline, LLC. $18.72 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116645751 GlaxoSmithKline, LLC. $15.43 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131091960 PFIZER INC. $25.30 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135968664 Lilly USA, LLC $14.42 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150150789 SHIELD THERAPEUTICS INC $23.37 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.